RethinkHIV researcher Dr. Anna Vassall of London School of Hygiene & Tropical Medicine is a signatory of a full-page advertisement in the New York Times with 266 other economists calling for greater health investment.
The declaration states, “Our generation has a historic opportunity to achieve a ‘grand convergence’ in global health, reducing preventable maternal, child and infectious disease deaths to universally low levels by 2035.”
Ahead of the adoption of the Global Goals at the United Nations in New York, the economists called on world leaders to prioritize a “pro-poor pathway to universal health coverage”.
President Emeritus and Charles W. Eliot Professor of Harvard University, Lawrence Summers, wrote a related commentary on the urgent need to invest in health, which he posted on his blog and in the Financial Times and Washington Post. Other signatories included Bjorn Lomborg and Stef Bertozzi.
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.